These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 10560354)
1. Immunohistochemical expression of pi class glutathione S-transferase in the basal cell layer of benign prostate tissue following chronic treatment with finasteride. Montironi R; Mazzucchelli R; Pomante R; Thompson D; Duval da Silva V; Vaught L; Bartels PH J Clin Pathol; 1999 May; 52(5):350-4. PubMed ID: 10560354 [TBL] [Abstract][Full Text] [Related]
2. Expression of pi-class glutathione S-transferase: two populations of high grade prostatic intraepithelial neoplasia with different relations to carcinoma. Montironi R; Mazzucchelli R; Stramazzotti D; Pomante R; Thompson D; Bartels PH Mol Pathol; 2000 Jun; 53(3):122-8. PubMed ID: 10897330 [TBL] [Abstract][Full Text] [Related]
3. Glutathione S-transferase PI (GST-pi) class expression by immunohistochemistry in benign and malignant prostate tissue. Cookson MS; Reuter VE; Linkov I; Fair WR J Urol; 1997 Feb; 157(2):673-6. PubMed ID: 8996396 [TBL] [Abstract][Full Text] [Related]
4. Glutathione S-transferase: differential expression of alpha, mu, and pi isoenzymes in benign prostate, prostatic intraepithelial neoplasia, and prostatic adenocarcinoma. Bostwick DG; Meiers I; Shanks JH Hum Pathol; 2007 Sep; 38(9):1394-401. PubMed ID: 17555796 [TBL] [Abstract][Full Text] [Related]
5. Treatment of benign prostatic hyperplasia with 5-alpha-reductase inhibitor: morphological changes in patients who fail to respond. Montironi R; Valli M; Fabris G J Clin Pathol; 1996 Apr; 49(4):324-8. PubMed ID: 8655710 [TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical evaluation of type IV collagenase (72-kd metalloproteinase) in prostatic intraepithelial neoplasia. Montironi R; Lucarini G; Castaldini C; Galluzzi CM; Biagini G; Fabris G Anticancer Res; 1996; 16(4A):2057-62. PubMed ID: 8712742 [TBL] [Abstract][Full Text] [Related]
7. Does long-term finasteride therapy affect the histologic features of benign prostatic tissue and prostate cancer on needle biopsy? PLESS Study Group. Proscar Long-Term Efficacy and Safety Study. Yang XJ; Lecksell K; Short K; Gottesman J; Peterson L; Bannow J; Schellhammer PF; Fitch WP; Hodge GB; Parra R; Rouse S; Waldstreicher J; Epstein JI Urology; 1999 Apr; 53(4):696-700. PubMed ID: 10197843 [TBL] [Abstract][Full Text] [Related]
8. Histologic influence of doxazosin and finasteride in benign prostatic hyperplasia accompanying chronic inflammation. Park DS; Shim JY Urol Int; 2008; 81(4):441-6. PubMed ID: 19077407 [TBL] [Abstract][Full Text] [Related]
9. Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis. De Marzo AM; Marchi VL; Epstein JI; Nelson WG Am J Pathol; 1999 Dec; 155(6):1985-92. PubMed ID: 10595928 [TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical expression of pi-class glutathione S-transferase is down-regulated in adenocarcinoma of the prostate. Moskaluk CA; Duray PH; Cowan KH; Linehan M; Merino MJ Cancer; 1997 Apr; 79(8):1595-9. PubMed ID: 9118044 [TBL] [Abstract][Full Text] [Related]
12. Effects of combination endocrine treatment on normal prostate, prostatic intraepithelial neoplasia, and prostatic adenocarcinoma. Montironi R; Magi-Galluzzi C; Muzzonigro G; Prete E; Polito M; Fabris G J Clin Pathol; 1994 Oct; 47(10):906-13. PubMed ID: 7525657 [TBL] [Abstract][Full Text] [Related]
13. Glutathione S-transferase pi is upregulated in the stromal compartment of hormone independent prostate cancer. Li M; Ittmann MM; Rowley DR; Knowlton AA; Vaid AK; Epner DE Prostate; 2003 Jul; 56(2):98-105. PubMed ID: 12746833 [TBL] [Abstract][Full Text] [Related]
14. Prostate stem cell compartments: expression of the cell cycle inhibitor p27Kip1 in normal, hyperplastic, and neoplastic cells. De Marzo AM; Meeker AK; Epstein JI; Coffey DS Am J Pathol; 1998 Sep; 153(3):911-9. PubMed ID: 9736039 [TBL] [Abstract][Full Text] [Related]
15. Expression of basic fibroblast growth factor and its receptors FGFR1 and FGFR2 in human benign prostatic hyperplasia treated with finasteride. Sáez C; González-Baena AC; Japón MA; Giráldez J; Segura DI; Rodríguez-Vallejo JM; González-Esteban J; Miranda G; Torrubia F Prostate; 1999 Jul; 40(2):83-8. PubMed ID: 10386468 [TBL] [Abstract][Full Text] [Related]
16. Decreased suburethral prostatic microvessel density in finasteride treated prostates: a possible mechanism for reduced bleeding in benign prostatic hyperplasia. Hochberg DA; Basillote JB; Armenakas NA; Vasovic L; Shevchuk M; Pareek G; Fracchia JA J Urol; 2002 Apr; 167(4):1731-3. PubMed ID: 11912398 [TBL] [Abstract][Full Text] [Related]
17. Finasteride upregulates expression of androgen receptor in hyperplastic prostate and LNCaP cells: implications for chemoprevention of prostate cancer. Hsieh JT; Chen SC; Yu HJ; Chang HC Prostate; 2011 Jul; 71(10):1115-21. PubMed ID: 21557276 [TBL] [Abstract][Full Text] [Related]
18. Evidence for atrophy and apoptosis in the prostates of men given finasteride. Rittmaster RS; Norman RW; Thomas LN; Rowden G J Clin Endocrinol Metab; 1996 Feb; 81(2):814-9. PubMed ID: 8636309 [TBL] [Abstract][Full Text] [Related]
19. Prevalent decrease of the EGF content in the periurethral zone of BPH tissue induced by treatment with finasteride or flutamide. Monti S; Sciarra F; Adamo MV; Toscano V; Trotta MC; Martini C; Lanzara S; Silverio FD J Androl; 1997; 18(5):488-94. PubMed ID: 9349746 [TBL] [Abstract][Full Text] [Related]
20. Dihydrotestosterone and the concept of 5alpha-reductase inhibition in human benign prostatic hyperplasia. Bartsch G; Rittmaster RS; Klocker H Eur Urol; 2000 Apr; 37(4):367-80. PubMed ID: 10765065 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]